Cargando…

Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens

Human immune system mice are highly valuable for in vivo dissection of human immune responses. Although they were employed for analyzing tuberculosis (TB) disease, there is little data on the spatial organization and cellular composition of human immune cells in TB granuloma pathology in this model....

Descripción completa

Detalles Bibliográficos
Autores principales: Arrey, Frida, Löwe, Delia, Kuhlmann, Stefanie, Kaiser, Peggy, Moura-Alves, Pedro, Krishnamoorthy, Gopinath, Lozza, Laura, Maertzdorf, Jeroen, Skrahina, Tatsiana, Skrahina, Alena, Gengenbacher, Martin, Nouailles, Geraldine, Kaufmann, Stefan H. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365439/
https://www.ncbi.nlm.nih.gov/pubmed/30766535
http://dx.doi.org/10.3389/fimmu.2019.00089
_version_ 1783393417220325376
author Arrey, Frida
Löwe, Delia
Kuhlmann, Stefanie
Kaiser, Peggy
Moura-Alves, Pedro
Krishnamoorthy, Gopinath
Lozza, Laura
Maertzdorf, Jeroen
Skrahina, Tatsiana
Skrahina, Alena
Gengenbacher, Martin
Nouailles, Geraldine
Kaufmann, Stefan H. E.
author_facet Arrey, Frida
Löwe, Delia
Kuhlmann, Stefanie
Kaiser, Peggy
Moura-Alves, Pedro
Krishnamoorthy, Gopinath
Lozza, Laura
Maertzdorf, Jeroen
Skrahina, Tatsiana
Skrahina, Alena
Gengenbacher, Martin
Nouailles, Geraldine
Kaufmann, Stefan H. E.
author_sort Arrey, Frida
collection PubMed
description Human immune system mice are highly valuable for in vivo dissection of human immune responses. Although they were employed for analyzing tuberculosis (TB) disease, there is little data on the spatial organization and cellular composition of human immune cells in TB granuloma pathology in this model. We demonstrate that human immune system mice, generated by transplanted human fetal liver derived hematopoietic stem cells develop a continuum of pulmonary lesions upon Mycobacterium tuberculosis aerosol infection. In particular, caseous necrotic granulomas, which contribute to prolonged TB treatment time, developed, and had cellular phenotypic spatial-organization similar to TB patients. By comparing two recommended drug regimens, we confirmed observations made in clinical settings: Adding Moxifloxacin to a classical chemotherapy regimen had no beneficial effects on bacterial eradication. We consider this model instrumental for deeper understanding of human specific features of TB pathogenesis and of particular value for the pre-clinical drug development pipeline.
format Online
Article
Text
id pubmed-6365439
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63654392019-02-14 Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens Arrey, Frida Löwe, Delia Kuhlmann, Stefanie Kaiser, Peggy Moura-Alves, Pedro Krishnamoorthy, Gopinath Lozza, Laura Maertzdorf, Jeroen Skrahina, Tatsiana Skrahina, Alena Gengenbacher, Martin Nouailles, Geraldine Kaufmann, Stefan H. E. Front Immunol Immunology Human immune system mice are highly valuable for in vivo dissection of human immune responses. Although they were employed for analyzing tuberculosis (TB) disease, there is little data on the spatial organization and cellular composition of human immune cells in TB granuloma pathology in this model. We demonstrate that human immune system mice, generated by transplanted human fetal liver derived hematopoietic stem cells develop a continuum of pulmonary lesions upon Mycobacterium tuberculosis aerosol infection. In particular, caseous necrotic granulomas, which contribute to prolonged TB treatment time, developed, and had cellular phenotypic spatial-organization similar to TB patients. By comparing two recommended drug regimens, we confirmed observations made in clinical settings: Adding Moxifloxacin to a classical chemotherapy regimen had no beneficial effects on bacterial eradication. We consider this model instrumental for deeper understanding of human specific features of TB pathogenesis and of particular value for the pre-clinical drug development pipeline. Frontiers Media S.A. 2019-01-31 /pmc/articles/PMC6365439/ /pubmed/30766535 http://dx.doi.org/10.3389/fimmu.2019.00089 Text en Copyright © 2019 Arrey, Löwe, Kuhlmann, Kaiser, Moura-Alves, Krishnamoorthy, Lozza, Maertzdorf, Skrahina, Skrahina, Gengenbacher, Nouailles and Kaufmann. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Arrey, Frida
Löwe, Delia
Kuhlmann, Stefanie
Kaiser, Peggy
Moura-Alves, Pedro
Krishnamoorthy, Gopinath
Lozza, Laura
Maertzdorf, Jeroen
Skrahina, Tatsiana
Skrahina, Alena
Gengenbacher, Martin
Nouailles, Geraldine
Kaufmann, Stefan H. E.
Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens
title Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens
title_full Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens
title_fullStr Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens
title_full_unstemmed Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens
title_short Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens
title_sort humanized mouse model mimicking pathology of human tuberculosis for in vivo evaluation of drug regimens
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365439/
https://www.ncbi.nlm.nih.gov/pubmed/30766535
http://dx.doi.org/10.3389/fimmu.2019.00089
work_keys_str_mv AT arreyfrida humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT lowedelia humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT kuhlmannstefanie humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT kaiserpeggy humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT mouraalvespedro humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT krishnamoorthygopinath humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT lozzalaura humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT maertzdorfjeroen humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT skrahinatatsiana humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT skrahinaalena humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT gengenbachermartin humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT nouaillesgeraldine humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens
AT kaufmannstefanhe humanizedmousemodelmimickingpathologyofhumantuberculosisforinvivoevaluationofdrugregimens